Stanozolol Suspension Research Overview
Stanozolol suspension is a synthetic anabolic steroid derived from dihydrotestosterone, formulated as an aqueous suspension for research purposes. This compound exhibits a modified steroid structure with enhanced anabolic properties while demonstrating reduced androgenic activity in preclinical models. Zhengzhou Pharmaceutical Co. produces this research-grade suspension for in-vitro laboratory investigations examining anabolic steroid mechanisms and tissue-selective effects. Researchers investigating steroid pharmacology can examine stanozolol’s unique molecular profile, which includes a pyrazole ring modification that alters its binding affinity and metabolic properties compared to testosterone-based compounds.
Research Applications
Laboratory studies examining stanozolol suspension focus on its anabolic-to-androgenic ratio, which demonstrates tissue-selective activity in experimental models. Research applications include investigating protein synthesis pathways, nitrogen retention mechanisms, and collagen synthesis modulation in cell culture systems. Scientists at Stroid UK Shop can explore stanozolol’s effects on gene expression patterns related to muscle tissue development and bone matrix formation. The compound’s aqueous suspension format allows for precise dosimetric studies in laboratory settings, enabling researchers to evaluate bioavailability and pharmacokinetic parameters. Studies may also examine stanozolol’s interaction with androgen receptors and its potential for hepatotoxicity assessment in liver cell models. Comparative research with other compounds from our stanozolol collection, SARM alternatives, or peptide modulators provides valuable insights into structure-activity relationships and tissue selectivity patterns.
Technical Specifications
| Parameter | Value |
|---|---|
| Chemical Name | 17α-methyl-17β-hydroxy-5α-androst-2-eno[3,2-c]pyrazole |
| CAS Number | 10418-03-8 |
| Molecular Formula | C₂₁H₃₂N₂O |
| Molecular Weight | 328.49 g/mol |
| Formulation | Aqueous suspension |
| Manufacturer | ZPHC Zhengzhou Pharmaceutical Co. |
| Storage Conditions | Room temperature, protect from light |
| Stability | Stable when stored properly |
Research Compliance Statement
This stanozolol suspension is manufactured by Zhengzhou Pharmaceutical Co. exclusively for laboratory research purposes and in-vitro studies. Not approved for human consumption, clinical use, or any application outside controlled research environments. Researchers must maintain appropriate laboratory safety protocols and comply with institutional guidelines for anabolic steroid research. All investigations should be conducted by qualified personnel in accredited research facilities with proper ventilation and safety equipment. This product is intended solely for advancing scientific understanding of anabolic steroid mechanisms and should not be used for any purpose other than legitimate laboratory research.
